Detalles de la búsqueda
1.
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.
BMC Cancer
; 24(1): 171, 2024 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310262
2.
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5.
BMC Cancer
; 18(1): 954, 2018 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30286739
3.
Re-irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectives.
J Appl Clin Med Phys
; 19(6): 341-345, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30371001
4.
The Vancouver rapid access clinic for palliative lung radiation, providing more than just rapid access.
Support Care Cancer
; 23(1): 125-32, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25001608
5.
Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.
Int J Radiat Oncol Biol Phys
; 118(5): 1497-1506, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38220069
6.
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial.
Radiother Oncol
; 182: 109576, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36822355
7.
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial.
Int J Radiat Oncol Biol Phys
; 114(4): 617-626, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35667528
8.
Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 Trial.
Int J Radiat Oncol Biol Phys
; 114(5): 856-861, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35840110
9.
Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial.
JAMA Oncol
; 8(11): 1644-1650, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36173619
10.
Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life.
J Neurooncol
; 105(2): 337-44, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21520004
11.
Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases.
Support Care Cancer
; 19(11): 1849-55, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20957394
12.
Radiation Oncology Resident and Program Director Perceptions of the Job Market and Impact on Well-being.
Cureus
; 12(3): e7187, 2020 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32269868
13.
A Patient-centered Approach to Evaluate the Information Needs of Women With Ductal Carcinoma In Situ.
Am J Clin Oncol
; 40(6): 574-581, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25730602
14.
Volumetric Radiosurgery for 1 to 10 Brain Metastases: A Multicenter, Single-Arm, Phase 2 Study.
Int J Radiat Oncol Biol Phys
; 94(2): 312-21, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26678660
15.
Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
Lung Cancer
; 49(1): 109-15, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15949596
16.
The impact of peer review of volume delineation in stereotactic body radiation therapy planning for primary lung cancer: a multicenter quality assurance study.
J Thorac Oncol
; 9(4): 527-33, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24736076
17.
Thymoma: a population-based study of the management and outcomes for the province of British Columbia.
J Thorac Oncol
; 8(1): 109-17, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23242441
18.
Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.
Breast
; 22(5): 919-25, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23721853
19.
Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.
Patient Educ Couns
; 93(1): 114-21, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23747087
20.
Evaluation of dosimetric consequences of seroma contour variability in accelerated partial breast irradiation using a constructed representative seroma contour.
Int J Radiat Oncol Biol Phys
; 84(2): 527-32, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22342091